NCT00926393View on ClinicalTrials.gov

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

PHASE4CompletedINTERVENTIONAL

Enrollment

139

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Bipolar Depression

Interventions

DRUG

Quetiapine Immediate Release

Oral, 3 tablets daily: (2 x 25 mg + 1 x 50 mg) at one time each day

DRUG

Quetiapine Extended Release

Oral, 3 tablets daily: (2 x 25 mg + 1 x 50 mg) at one time each day

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT00926393 - Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression | Biotech Hunter | Biotech Hunter